Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
Abstract The COVID19 pandemic, caused by SARS-CoV-2, has infected more than 200 million people worldwide. Due to the rapid spreading of SARS-CoV-2 and its impact, it is paramount to find effective treatments against it. Human neutralizing antibodies are an effective method to fight viral infection....
Guardado en:
Autores principales: | Mohamed Hendy, Samuel Kaufman, Mauricio Ponga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/801d7d3cdd074e7e8a37de7234682b42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Lin Yang, et al.
Publicado: (2021) -
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
por: Allison J. Greaney, et al.
Publicado: (2021) -
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Zhiqiang Ku, et al.
Publicado: (2021) -
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Zhiqiang Ku, et al.
Publicado: (2021) -
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
por: Yusuke Higuchi, et al.
Publicado: (2021)